XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.87

-1.4%

Jan 22 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (12419)	12/10/1999 8:02:00 AM
From: xomadog4	Read Replies (1) of 17367

Prohost: Increasing optimism as to Neuprex approval Who's Prohost? When this meeting with the FDA finally takes place, and they say the BLA should be filed for Neuprex with a fast track approval,or there is other favorable news concerning the Phase III trial for hu1124 (cd11a?)for psoriasis w/DNA starting, or a deal for/with someone on Mycoprex, there will be stock for sale. Until then, the stock is for sale. It will take more than 1,000 shares by Peter Davis to help this stock. Why did he bother?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next